These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29282754)

  • 1. Explained variation in shared frailty models.
    Gleiss A; Gnant M; Schemper M
    Stat Med; 2018 Apr; 37(9):1482-1490. PubMed ID: 29282754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical controversies in clinical research: the importance of importance.
    Gleiss A; Zeillinger R; Braicu EI; Trillsch F; Vergote I; Schemper M
    Ann Oncol; 2016 Jul; 27(7):1185-9. PubMed ID: 27052655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of model misspecification in shared frailty survival models.
    Gasparini A; Clements MS; Abrams KR; Crowther MJ
    Stat Med; 2019 Oct; 38(23):4477-4502. PubMed ID: 31328285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating hospital heterogeneity with a competing risks frailty model.
    Rueten-Budde AJ; Putter H; Fiocco M
    Stat Med; 2019 Jan; 38(2):269-288. PubMed ID: 30338563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measures of explained variation for a regression model used in survival analysis.
    Akazawa K
    J Med Syst; 1997 Aug; 21(4):229-38. PubMed ID: 9442437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling spatial survival data using semiparametric frailty models.
    Li Y; Ryan L
    Biometrics; 2002 Jun; 58(2):287-97. PubMed ID: 12071401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the prediction accuracy of cure in the Cox proportional hazards cure model: an application to breast cancer data.
    Asano J; Hirakawa A; Hamada C
    Pharm Stat; 2014; 13(6):357-63. PubMed ID: 25044997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative importance of prognostic factors in studies of survival.
    Schemper M
    Stat Med; 1993 Dec; 12(24):2377-82. PubMed ID: 8134740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procedures for testing the homogeneity of relative difference in sparse data.
    Lui KJ
    Stat Med; 2006 Feb; 25(4):685-97. PubMed ID: 16007573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frailty modelling for survival data from multi-centre clinical trials.
    Ha ID; Sylvester R; Legrand C; Mackenzie G
    Stat Med; 2011 Jul; 30(17):2144-59. PubMed ID: 21563206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hierarchical likelihood inference on clustered competing risks data.
    Christian NJ; Ha ID; Jeong JH
    Stat Med; 2016 Jan; 35(2):251-67. PubMed ID: 26278918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probability imputation revisited for prognostic factor studies.
    Schemper M; Heinze G
    Stat Med; 1997 Jan 15-Feb 15; 16(1-3):73-80. PubMed ID: 9004384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-study hierarchical modeling of stratified clinical trial data.
    Johnson B; Carlin BP; Hodges JS
    J Biopharm Stat; 1999 Nov; 9(4):617-40. PubMed ID: 10576407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On proportional hazards assumption under the random effects models.
    Xu R; Gamst A
    Lifetime Data Anal; 2007 Sep; 13(3):317-32. PubMed ID: 17638076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive accuracy and explained variation.
    Schemper M
    Stat Med; 2003 Jul; 22(14):2299-308. PubMed ID: 12854094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic frailty models based on compound birth-death processes.
    Putter H; van Houwelingen HC
    Biostatistics; 2015 Jul; 16(3):550-64. PubMed ID: 25681608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying degrees of necessity and of sufficiency in cause-effect relationships with dichotomous and survival outcomes.
    Gleiss A; Schemper M
    Stat Med; 2019 Oct; 38(23):4733-4748. PubMed ID: 31386230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frailty proportional mean residual life regression for clustered survival data: A hierarchical quasi-likelihood method.
    Huang R; Xiang L; Ha ID
    Stat Med; 2019 Oct; 38(24):4854-4870. PubMed ID: 31418907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-interpretation of PAM50 gene expression as quantitative tumor dimensions shows utility for clinical trials: application to prognosis and response to paclitaxel in breast cancer.
    Camp NJ; Madsen MJ; Herranz J; Rodríguez-Lescure Á; Ruiz A; Martín M; Bernard PS
    Breast Cancer Res Treat; 2019 May; 175(1):129-139. PubMed ID: 30673970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment and comparison of prognostic classification schemes for survival data.
    Graf E; Schmoor C; Sauerbrei W; Schumacher M
    Stat Med; 1999 Sep 15-30; 18(17-18):2529-45. PubMed ID: 10474158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.